[1] RUPALI L S, SHASHIKANT N D, NILESH K, et al. Nanosuspension:a review [J]. Int J Pharm Sci Rev Res, 2013, 22(1):98-106.
[2] YUAN Y, SUN Y N, LU C H. An overview of researches on biological characteristics and mechanism of nanomedicine [J]. Chin Pharmacol Bull(中国药理学通报), 2013, 29(8):1180-1184.
[3] D′SOUZA S S. A review of in vitro drug release test methods for nano-sized dosage forms [J]. Adv Pharm, 2014, Article ID 304757.
[4] CHEN L, TANG M, LU W G. Stability and controlling strategies in particle size of nanosuspension [J]. World Clin Drugs(世界临床药物), 2010, 31(4):245-249.
[5] YUE P F,DAN J X,XIE Y B, et al. Research progress and thinking on nano-suspensions delivery system of indissoluble substance of traditional Chinese medicine [J]. World Chin Med(世界中医药), 2015, 10(3):310-314.
[6] LIU L, XU L Z, HE X W, et al. Preparation and in vitro release of self-assembled neurotoxin-loaded nanoparticles of core-shell type [J]. Chin Pharm J(中国药学杂志), 2009, 44(14):1084-1088.
[7] CHIDAMBARAM N, BURGESS D J. A novel in vitro release method for submicron-sized dispersed systems [J]. AAPS Pharm Sci, 1999, 1(3):1-9.
[8] WANG L, LIU Y, FENG N P. Development of in vitro release methods in lipid nanoparticles drug delivery system [J]. Chin J Exp Tradit Med Form(中国实验方剂学杂志), 2013, 19(18):350-356.
[9] SUN Q, YANG L, CHEN X L, et al. Evaluation of release behaviors of pyridostigmine bromide nanoemulsion in vitro [J]. Chin Hosp Pharm J(中国医院药学杂志), 2015, 35(2):132-135.
[10] LV C H. Research of drug release:an overview [J]. Anhui Med Pharm J(安徽医药), 2007, 11(1):76-77.
[11] D′SOUZA S S, DELUCA P P. Methods to assess in vitro drug release from injectable polymeric particulate systems [J]. Pharm Res, 2006, 23(3):460-474.
[12] LAI F, PINI E, ANGIONI G, et al. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets [J]. Eur J Pharm Biopharm, 2011, 7(5):1-7.
[13] ZHANG Y Z, WANG H, LI C J, et al. A novel three-dimensional large-pore mesoporous carbon matrix as a potential nanovehicle for the fast release of the poorly water-soluble drug, celecoxib [J]. Pharm Res, 2014, 31(4):1059-1070.
[14] CETIN M, ATILA A, KADIOGLU Y. Formulation and in vitro characterization of Eudragit L100 and EudragitL100-PLGA nanoparticles containing diclofenac sodium [J]. AAPS Pharm Sci Tech, 2010, 11(3):1250-1256.
[15] HENG D, CUTLER D J, CHAN H K, et al. What is a suitable dissolution method for drug nanoparticles? [J]. Pharm Res, 2008, 25(7):1696-1701.
[16] YUE P F, LU X Y, ZHANG Z Z, et al. The study on the entrapment efficiency and in vitro release of puerarin submicron emulsion [J]. AAPS Pharm Sci Tech, 2009, 10(2):376-383.
[17] DANHIER F, LECOUTURIER N, VROMAN B, et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles:in vitro and in vivo evaluation [J]. J Controlled Release, 2009, 133(1):11-17.
[18] WALLACE S J, LI J, NATION R L, et al. Drug release from nanomedicines:selection of appropriate encapsulation and release methodology [J]. Drug Deliv Transl Res, 2012, 2(4):284-292.
[19] MAHKAM M, HOSSEINZADEH F, GALEHASSADI M. Preparation of ionic liquid functionalized silica nanoparticles for oral drug delivery [J]. J Biomater Nanobiotechnol, 2012, 3(3):391-395.
[20] LI Y P, PEI Y Y, ZHANG X Y, et al. PEGylated PLGA nanoparticles as protein carriers:synthesis, preparation and biodistribution in rats [J]. J Controlled Release, 2001, 71(2):203-211.
[21] PRABHA S, ZHOU W Z, PANYAM J, et al. Size-dependency of nanoparticle-mediated gene transfection:studies with fractionated nanoparticles [J]. Int J Pharm, 2002, 244(1-2):105-115.
[22] FOTAKI N. Flow-through cell apparatus(USP apparatus 4):operation and features [J]. Dissol Technol, 2011, 18(4):46-49.
[23] ZHAO J, YI H, LIU X Q, et al. Progress in application of flow-through cell method for determination of drug dissolution [J]. Chin Pharm J(中国药学杂志), 2014, 49(17):1486-1490.
[24] HU P Y, ZHENG Q, LIU Y J, et al. Preparation and in vitro drug-release behavior of sophoridine nano-liposomes using pH-gradients method coupled with reverse evaporation technique [J]. Chin J New Drugs(中国新药杂志), 2011, 20(14):1275-1279.
[25] LIU D, LI S B, BAO J, et al. Preparation, in vitro release and pharmacokinetics of paclitaxel lipid nanoparticles for intravenous injection [J]. Chin Pharm J(中国药学杂志), 2009, 44(17):1320-1326.
[26] UPRIT S, SAHUK R K, ROY A, et al. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia [J]. Saudi Pharm J, 2013, 21(4):379-385.
[27] ABDEL-MOTTALEB M M A, LAMPRECHT A. Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I [J]. Drug Dev Ind Pharm, 2011, 37(2):178-184.
[28] CAO X, DENG W W, FU M, et al. In vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles [J]. Int J Nanomed, 2012, 7(2):753-762.
[29] MAGHSOUDI A, SHOJAOSADATI S A, VASHEGHANI FARAHANI E, et al. 5-fluorouracil-loaded BSA nanoparticles:formulation optimization and in vitro release study [J]. AAPS Pharm Sci Tech, 2008, 9(4):1092-1096.
[30] BHARDWAJ U, BURGESS D J. A novel USP apparatus 4 based release testing method for dispersed systems [J]. Int J Pharm, 2010, 388(1-2):287-294.
[31] MORA L, CHUMBIMUNI-TORRES K Y, CLAWSON C, et al. Real-time electrochemical monitoring of drug release from therapeutic nanoparticles [J]. J Controlled Release, 2009, 140(1):69-73.
[32] HELLE A, HIRSJARVI S, PELTONEN L, et al. Novel, dynamic on-line analytical separation system for dissolution of drugs from poly(lactic acid) nanoparticles [J]. J Pharm Biomed, 2010, 51(1):125-130.
[33] MICHALOWSKI C B, GUTERRES S S, COSTA T D. Microdialysis for evaluating the entrapment and release of a lipophilic drug from nanoparticles [J]. J Pharm Biomed, 2004, 35(5):1093-1100.
[34] KUMAR R, NAGARWAL R C, DHANAWAT M, et al. In vitro and in vivo study of indomethacin loaded gelatin nanoparticles [J]. J Biomed Nanotechnol, 2011, 7(2):1-9.
[35] YI Y N, TU L X, HU K L, et al. The construction of puerarin nanocrystals and its pharmacokinetic and in vivo-in vitro correlation(IVIVC) studies on beagle dog [J]. Colloid Surface B Biointerfaces, 2015, 133:164-170.